Skip to main content
. 2014 Sep 22;14:689. doi: 10.1186/1471-2407-14-689

Table 2.

The inhibitory activity of Jac-A on tumour cells via MTT Assay (IC 50 , μ M, n = 4, mean ± SD)

Compound Breast cancer Colon cancer Lung cancer Liver cancer Leukaemia
MBA-MB-231 T47D LOVO A549 HepG2 K562 HL-60 THP-1
Jac-A 22.61 ± 1.2 12.53 ± 1.6 33.24 ± 2.1 18.8 ± 1.6 10.71 ± 1.4 6.52 ± 0.36 9.01 ± 0.47 9.92 ± 0.95
Doxorubicina 0.13 ± 0.01 0.25 ± 0.02 0.24 ± 0.01 0.11 ± 0.01 0.34 ± 0.02 0.55 ± 0.03 0.68 ± 0.02 0.52 ± 0.03

aPositive control.